Analysts See $1.62 EPS for ICU Medical, Inc. (ICUI); DSV A/S ORDINARY SHARES DENMARK (DSDVF) Shorts Down By 2.15%

April 17, 2018 - By Hazel Jackson

ICU Medical, Inc. (NASDAQ:ICUI) Logo

Analysts expect ICU Medical, Inc. (NASDAQ:ICUI) to report $1.62 EPS on May, 9 after the close.They anticipate $0.14 EPS change or 9.46% from last quarter’s $1.48 EPS. ICUI’s profit would be $32.86M giving it 39.51 P/E if the $1.62 EPS is correct. After having $2.70 EPS previously, ICU Medical, Inc.’s analysts see -40.00% EPS growth. The stock decreased 0.08% or $0.2 during the last trading session, reaching $256.05. About 58,691 shares traded. ICU Medical, Inc. (NASDAQ:ICUI) has risen 61.26% since April 17, 2017 and is uptrending. It has outperformed by 49.71% the S&P500.

DSV A/S ORDINARY SHARES DENMARK (OTCMKTS:DSDVF) had a decrease of 2.15% in short interest. DSDVF’s SI was 273,000 shares in April as released by FINRA. Its down 2.15% from 279,000 shares previously. With 400 avg volume, 683 days are for DSV A/S ORDINARY SHARES DENMARK (OTCMKTS:DSDVF)’s short sellers to cover DSDVF’s short positions. The SI to DSV A/S ORDINARY SHARES DENMARK’s float is 0.15%. It closed at $79 lastly. It is up 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

DSV A/S provides transport and logistics services in Europe, the Middle East, Africa, North America and South America, Asia, Australia, and the Pacific. The company has market cap of $. It operates in three divisions: DSV Air & Sea, DSV Road, and DSV Solutions. It currently has negative earnings. The firm offers air and sea freight services, and standard and industry-specific logistics solutions.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $5.19 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics. It has a 77.83 P/E ratio. The company's infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

Among 5 analysts covering ICU Medical (NASDAQ:ICUI), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. ICU Medical had 11 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating by Roth Capital given on Friday, November 6. The stock of ICU Medical, Inc. (NASDAQ:ICUI) has “Buy” rating given on Tuesday, August 11 by Roth Capital. The stock of ICU Medical, Inc. (NASDAQ:ICUI) has “Buy” rating given on Friday, March 11 by Gabelli. Gabelli maintained ICU Medical, Inc. (NASDAQ:ICUI) on Friday, August 11 with “Buy” rating. TH Capital maintained the stock with “Buy” rating in Tuesday, August 11 report. Roth Capital maintained it with “Hold” rating and $17200 target in Wednesday, August 9 report. As per Tuesday, August 11, the company rating was maintained by Piper Jaffray. TH Capital maintained it with “Buy” rating and $130 target in Friday, November 6 report. The stock of ICU Medical, Inc. (NASDAQ:ICUI) earned “Hold” rating by Zacks on Monday, August 17.

Since October 19, 2017, it had 0 insider purchases, and 5 insider sales for $21.84 million activity. The insider Lamb Scott E sold $5.20M. $1.65 million worth of ICU Medical, Inc. (NASDAQ:ICUI) was sold by LOPEZ GEORGE A. $18.58M worth of stock was sold by Jain Vivek on Thursday, October 19. Shares for $170,140 were sold by SWINNEY ROBERT S on Friday, January 19.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts